Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine combined with butorphanol versus butorphanol alone for perioperative analgesia in thoracoscopic radical resection of lung cancer
ChiCTR2100046939Phase 4Recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine, butorphanol and propofol in postoperative pain (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Postoperative VAS score. Started May 2021; status: recruiting.
02
Drugs
esketaminebutorphanolpropofol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100046939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046939.